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Abstract
Background: Semi-quantitative bacteruria counts (s-QBC) are important in the diagnosis of urinary tract infection
(UTI) due to most uropathogens. The prognostic value of s-QBC for diagnosis of UTI due to group B streptococcus
(GBS) is unknown. In this study, we assessed the value of s-QBC for differentiating acute GBS UTI from
asymptomatic bacteruria (ABU), independent of other potential prognostic indicators.
Methods: Medical record review and urinalysis (UA) values for 1593 patients who had urinary GBS isolated
(103 to ≥105 CFU/ml) during a four-year period were analyzed using binary logistic regression to determine the
predictive values of s-QBC, age, and gender for infection category (acute UTI, ABU) based on the clinical diagnosis.
Results: s-QBC alone had a strong predictive value for infection category but only for ABU. Multivariate logistic
regression showed similar predictive power of s-QBC for infection category using age as a co-predictor, which was
also independently associated with infection category. Typical s-QBC cut-off values that are commonly used in
diagnostic settings had no significant power in predicting infection category. Among other UA measures,
proteinuria and hematuria were significantly associated with acute infection.
Conclusions: Together, these data show that s-QBC is not useful in the differential diagnosis of GBS UTI. Among
the patients in this study, age was an equally effective prognostic indicator compared to s-QBC for identifying
high- and low-risk patients for acute GBS UTI. Collectively, these findings indicate that age-based associations may
be equally as useful as s-QBC for predicting infection category in the setting of adult patients with GBS-positive
urine cultures.
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Background
Bacterial urinary tract infections (UTIs) are among the
most common infectious diseases of humans. One in
three women will contract a UTI in their lifetime [1], and
approximately 3% of these individuals will experience
more than one infection per year [2,3]. UTIs contribute
to approximately 60 million hospital visits per year
with substantial associated costs to the healthcare industry
[2-5]. Over 80% of UTIs are caused by Escherichia coli and
other Gram-negative bacteria including Pseudomonas spp.,
Klebsiella spp., and Acinetobacter spp. many of which
are increasingly being associated with antibiotic resistance
[6-9].
Gram-positive bacteria including enterococci, staphylo-
cocci, and streptococci are also important uropathogens.
These organisms are less prevalent compared to Enterobac-
teriaceae but constitute major contributors to the global
burden of UTI [6,7]. Streptococcus agalactiae, also known
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as group B streptococcus (GBS), emerged as an important
cause of acute UTI in adults in the 1990’s, and various
forms of GBS infection of the urinary tract have been
described in subsequent studies [10-14]. While generally
associated with maternal cervicovaginal colonization and
neonatal disease, GBS also frequently causes serious infec-
tions including acute UTI in older persons and those with
chronic medical illness [15,16]. The spectrum of GBS UTI
encompasses asymptomatic bacteruria (ABU), cystitis,
pyelonephritis, and urosepsis. Clinically, acute GBS UTI is
indistinguishable from acute UTI caused by other uro-
pathogenic bacteria, and diagnosis is made difficult by high
rates of sample contamination and asymptomatic infection
[14,17]. GBS is cultured from urine in approximately 2% of
all cases of clinically suspected UTI [10,14,18,19]. In
addition, urinary GBS complicates up to 7% of pregnancies
and contributes up to 10% of cases of pyelonephritis in
pregnancy [17,19-21]. GBS ABU is considered particularly
important during pregnancy due to the risk of vertical
transmission of the organism, which mandates antibiotic
therapy [22]. However, the relative significance of ABU due
to GBS in pregnancy compared to that due to other
organisms remains unclear [23,24].
Diagnostic strategies and use of the recommended
treatment guidelines for bacterial UTI varies substan-
tially between clinicians [25-28]. A combination of
symptoms in adults is considered predictive with a high
degree of probability for acute infection [29,30], how-
ever, there can be difficulties in applying general rules to
specific patient populations such as the elderly [28]. In
the laboratory setting, semi-quantitative bacteruria
counts (s-QBC) are routinely used as a diagnostic criter-
ion for individuals suspected of having a UTI. Typically,
s-QBC ranging between 103 and ≥105 CFU/ml are used
for laboratory-based prediction of acute uncomplicated
UTI in symptomatic patients. However, there exists
debate on the interpretation of s-QBC for diagnostic
criteria, and revisions of the traditionally accepted 105
CFU/ml cut-off value for acute UTI have emerged.
Several studies have suggested that this s-QBC cut-off
may be inappropriate for some clinical conditions,
and modified lower and higher cut-off values ranging
from 103 to ≥106 CFU/ml have been proposed [30-33]. In
addition, many laboratories continue to disregard s-QBC
of <105 CFU/ml for Gram-positive bacterial uropatho-
gens, and there remains debate regarding the prognostic
value of s-QBC of <104 CFU/ml for diagnosis of UTI due
to different organisms [34].
The aim of this study was to investigate the prognostic
value of s-QBC in the diagnosis of acute GBS UTI in the
setting of adult patients with urine cultures positive for
this organism. We retrospectively analyzed data for the
largest cohort of patients described to date in order to
examine whether s-QBC is useful as a predictor of acute
GBS UTI independent of other variables. The findings
show that s-QBC is not useful in the prediction of infec-
tion category, and suggest that age-based associations
may be equally as valuable compared to s-QBC for the
differential diagnosis of acute UTI and ABU due to GBS.
This study represents the first analysis of the role of
s-QBC in the diagnosis of GBS UTI, and despite
some limitations, the findings reported here provide
useful new insight into the interpretation of s-QBC
values for GBS UTI.
Methods
Study design
This study was conducted using clinical and laboratory
data from a single-center analysis of GBS UTI in
patients at University of Alabama at Birmingham (UAB)
Hospital conducted between August-2007 and August-
2008 [14]. Additional patients who attended the UAB
Hospital or surrounding clinics in the Birmingham area
in the subsequent 36-month period, and who tested
positive for urinary GBS, were also included in this
study. Consequently, the data analyzed here represents
all patients who presented with positive urine cultures
for GBS during the 48-month period between August-
2007 and July-2011. The study was performed with ap-
proval from and in accordance with the ethical standards
of the UAB committee on human experimentation and
the Helsinki Declaration (approval X070722011). Ethical
approval was also sought and granted by the Griffith
University human research ethics committee (approval
MSC/02/11/HREC). Written informed consent from
participants for the publication of images and patient
data was obtained according to the approvals from the
UAB committee on human experimentation and the
Griffith University human research ethics committee.
Study participants
The study subjects were adult patients (>18 yrs) encoun-
tered at UAB Hospital and surrounding clinics who
underwent clinical and microbiological assessment for
UTI because of symptoms indicating infection or as part
of routine patient screening. Urine samples were
obtained as clean-catch voided or catheterized samples
from all patients who underwent assessment for UTI
during the study period. This included inpatients,
patients that were evaluated in the emergency depart-
ment, and patients from various University Hospital out-
patient clinics. In cases where GBS was cultured from
urine (any count, single organism and mixed cultures)
the medical records for each patient were reviewed for
presenting symptoms at the time of sample collection
and demographic data were recorded. Potential prognos-
tic indicators were collected by medical record review to
encompass, on average, the three-week period either side
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of the date when the sample was collected. A provisional
diagnosis of acute GBS UTI was defined by the presence
of single-organism GBS bacteruria (any count; limits of
detection, 103 to ≥105 CFU/ml) with ≥1 symptom that
included dysuria, increased urinary frequency and/or ur-
gency, fever >38°C, flank pain and/or lumbar tenderness.
All GBS isolates cultured from urine were identified by
typical colony morphology on BBL trypticase soy agar
with 5% sheep blood (Becton, Dickinson and Company,
Franklin Lakes, NJ), tested for catalase, and grouped
using the Remel PathoDx latex agglutination kit
(Thermo Fisher Scientific, Lenexa, KS).
In cases where urinalysis (UA) was undertaken as part
of the diagnosis, acute UTI was confirmed on the basis of
positive urinary leukocyte esterase and significant pyuria
(≥107 white blood cells/L; non-spun). Thus, the case def-
inition for acute GBS UTI in this study was symptomatic
patients with a s-QBC of any level and UA findings con-
sistent with (C/W) acute infection. This definition was
taken as appropriate since acute UTI has been described
in patients with s-QBC as low as 102 CFU/ml in a prior
study [14]. Exclusion criteria were the isolation of multiple
organisms from urine, or incomplete medical records.
GBS ABU was defined as single-organism bacteruria of
any count, in the absence of UTI symptoms. This defin-
ition was chosen as rationally inclusive since GBS s-QBC
may vary considerably in individual patients over several
hours [14]. Additional inclusion criteria for GBS ABU
were negative UA laboratory values for leukocyte esterase
and pyuria, where UA had been undertaken. All study
subjects who satisfied these inclusion criteria were allo-
cated to one of two infection category groups: acute GBS
UTI, or ABU. This allowed analyses of relationships
between GBS UTI infection category, s-QBC, age, gender,
and other UA measures.
Data analysis
In the first stage of the statistical analysis, to determine
the overall predictive ability of s-QBC for differenti-
ation of acute GBS UTI from ABU, a number of uni-
variate logistic regression models were applied. These
models examined the independent effects of s-QBC,
age, and gender on infection category based on the
clinical diagnosis. The variables included were age, gen-
der, s-QBC, and infection category (acute UTI and
ABU). Specific interactions between potential prognos-
tic factors were subsequently evaluated using a multi-
variate logistic regression model in which all variables
were included to determine whether there existed any
significant relationships between each of the individual
potential prognostic factors in the prediction of infec-
tion category. The mean age and s-QBC for patients in
different infection categories were compared using an
Independent Sample t-test.
In the second stage of data analysis, we investigated
a subset of study subjects for whom UA testing had
been undertaken as part of the diagnosis. For all of the
cases that had UA performed, we analyzed the poten-
tial relationships between s-QBC and other laboratory
variables using a multivariate logistic regression model
to determine any significant interactions in the prediction
of infection category. The additional variables included
were UA measures of specific gravity, pH, proteinuria,
hematuria, glucose, ketones, and bilirubin. All statistical
analyses were carried out using IBM SPSS Statistics soft-
ware (Version 19.0). A level of significance of p < 0.05 was
selected for all of the analyses.
Results
Study subjects
A total of 1593 patients had GBS isolated from urine
during the study period. Within this cohort, 573
patients satisfied the inclusion criteria and were
assigned to either one of the two infection category
groups, acute GBS UTI or ABU. The majority of the
1020 residual subjects were excluded due to the isolation
of multiple organisms, or in some cases, due to unobtain-
able medical records. Gender and age data for the 573
study participants are shown in Table 1, with mean
s-QBC values for patients divided according to infection
category and gender. There were 497 women and 76
men among the 573 study subjects (ratio 6.5:1), with
average ages of 42.4 and 53.1 years, respectively (Table 1).
There were 147 patients diagnosed with acute GBS UTI,
and 426 patients with ABU. The mean age of patients
with acute UTI was 51.1 years, which was higher than
patients with ABU (41.3 years; p<0.001).
Bacteruria counts
The mean s-QBC for patients with acute GBS UTI was
63,980 ± 3,013 CFU/ml, which was significantly higher
than patients with ABU (46,279 ± 1,768 CFU/ml;
p≤0.001) (Table 1). These data, together with the data
described above, imply a relationship between infection
category and s-QBC, as well as infection category and
age for GBS UTI, in which patients with acute GBS UTI
are older, with higher s-QBC values, compared to
patients with ABU.
The differences in mean age and s-QBC values be-
tween patients in different infection category groups
related to women more so than men. Comparisons of
mean ages, divided according to gender, showed a sig-
nificantly higher mean age of women with acute UTI
(50.8 years) compared to women with ABU (39.7 years;
p<0.001). While the mean age of men with acute UTI
was also higher (58.7 years) compared to men with ABU
(51.5 years), this difference was not statistically signifi-
cant (p=0.151). Collectively, these data show that acute
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GBS UTI is associated with increased age in women, but
there is no significant difference in the mean age of men
with acute GBS UTI versus ABU.
Mean s-QBC values for women with acute UTI
(64,369 ± 3,169 CFU/ml) were significantly higher than
women with ABU (46,460 ± 1,181 CFU/ml) (p<0.001).
This was not true for men (Table 1). Overall, patients
with acute UTI were also more likely to be women than
men (OR 7.7, 95% CI, 4.2-13.9). Taken together, these
data show that the differences in mean age and s-QBC
values between individuals with acute UTI and ABU in
the study cohort were more strongly related to women
than men.
Potential prognostic indicators
Initial univariate logistic regression analysis revealed a
significant relationship between s-QBC and infection
category among all study subjects (Table 2). This was
consistent with the significantly higher mean s-QBC
value in acute UTI patients compared to that in indivi-
duals with ABU (Table 1). However, this relationship
between s-QBC and infection category (p<0.001) was
related to ABU cases only; i.e. s-QBC predicted 426/426
ABU cases correctly, but none of the 147 acute UTI
cases were predicted. As a result of this, we tested three
commonly applied s-QBC cut-off values in this model
(103, 104, 105 CFU/ml); however, none of these increased
the predictive power of s-QBC for infection category be-
cause the percentage of cases that were correctly clas-
sifed remained at 74.3% (Table 2). These data show that
while patients with acute GBS UTI have significantly
higher mean s-QBC values than those with ABU, s-QBC
alone is not useful as a predictor of infection category.
The univariate model also showed a significant relation-
ship between infection category and age, which classified
74.7% of subjects correctly into infection category with
significant predictive power (p=0.025). In this analysis,
age correctly predicted 3/147 patients with acute GBS
UTI and 425/426 patients with ABU, compared to 0/147,
and 426/426 predicted by s-QBC. Thus, age alone was
equally as useful as a predictor of UTI compared to
s-QBC in the overall study cohort as analysed using this
model.
We also analyzed potential relationships between s-QBC,
age, and gender for the prediction of infection category
using a multivariate model with the results shown in
Table 2. Here, the interactions between s-QBC and age did
not increase predictive power for infection category, and
similar predictive abilities were observed (p=0.021 to 0.024)
regardless of whether s-QBC was analyzed as a continuous
variable, or as groups using nominal cut-off values. Gender
did not alter the predictive ability of s-QBC when included
in the multivariate model (not shown). Thus, interactions
between s-QBC and age do not increase the predictive
power for GBS UTI infection category compared to either
variable alone.
We next analyzed whether an age-based cut-off might
increase the predictive power of s-QBC for infection cat-
egory. For this, we initially applied a cut-off of 40 years,
Table 1 Age, gender, and semi-quantitative bacteruria count (s-QBC) data for 573 patients with acute GBS UTI or ABU
at University of Alabama at Birmingham Hospital between August 2007 - July 2011
All Cases In Study (n=573) Acute UTI Cases (n=147) ABU Cases (n=426)
Females 497 (86.75%) 130 (88.44%) 367 (86.15%)
Mean age, and range 42.4, 18-93 50.8, 19-93 (p<0.001)† 36.7, 18-88
Mean s-QBC (CFU/mL) 51,145 ± 1,767 64,369 ± 3,169 (p<0.001)† 46,460 ± 1,181
Males 76 (13.25%) 17 (11.56%) 59 (13.85%)
Mean age, and range 53.1, 20-91 58.7, 25-91 (p=0.151)# 51.5, 20-80
Mean s-QBC (CFU/mL) 48,697 ± 4,580 61,000 ± 9,818 (p=0.165)# 45,153 ± 5,129
Combined 573 (100%) 147 (100%) 426 (100%)
Mean age, and range 43.8, 18-93 51.1, 19-93 (p<0.001)* 41.3, 18-88
Mean s-QBC (CFU/mL) 50,820 ± 1,557 63,980 ± 3,013 (p≤0.001)* 46,279 ± 1,768
Statistical Comparisons: †All Female Cases C/W acute UTI compared to All Female Cases C/W ABU. #All Male Cases C/W acute UTI compared to All Male Cases C/W
ABU. *All Cases C/W acute UTI compared to All Cases C/W ABU.
Table 2 Prognostic values of age and semi-quantitative
bacteruria count (s-QBC) for differentiating cases of acute
GBS UTI and ABU
Testing Model† s-QBC* Age* Constant % Correct#
Univariate (s-QBC)
Continuous s-QBC 1.13x10-5 NA -1.776 74.3%
C/O: 103, 104 or 105 0.92-1.10 NA -1.13-2.02 74.3%
Univariate (Age)
Continuous Age NA 0.025 -2.24 74.7%
Multivariate
Continuous s-QBC 1.04x10-5 0.021 -2.59 74.7%
C/O: 103, 104 or 105 0.76-0.87 0.022-4 -2.32-2.97 74.7%
† C/O: Cut-off value applied for s-QBC in CFU/ml. * Values in columns represent
p values. # Correct classification of cases as acute GBS UTI or ABU infection
category as determined by the testing model.
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which we based on the finding that individuals aged 40
years or older in this study were at significantly
increased risk for acute GBS UTI compared to ABU
(OR 1.7, 95% CI, 1.3-1.9). However, we found no in-
crease in the predictive power of s-QBC for acute UTI
using this model. Further analyses of alternative age cut-
offs revealed similar increased risks (35 years: OR 1.5,
95% CI, 1.3-1.7; 45 years: OR 1.6, 95% CI, 1.3-1.9; 50
years: OR 1.5, 95% CI, 1.2-1.8), but no significant effect
towards predictive power of s-QBC. Collectively, these
data show that age is a useful prognostic indicator for
infection category in GBS UTI, however, it does not en-
hance the predictive power of s-QBC in the differential
diagnosis of these infections.
In the second stage of the statistical analysis we inves-
tigated a subset of 245 subjects for whom UA testing
had been undertaken as part of the diagnosis. The la-
boratory findings from UA for these 245 patients,
divided according to infection category, are shown in
Table 3. In a multivariate model, there were no signifi-
cant interactions between any of the variables; i.e. the
predictive power of s-QBC was the same whether or not
the UA variables were included in the analysis. Separate
univariate models identified significant associations be-
tween infection category and proteinuria (p=0.03), and
infection category and haematuria (p=0.025; Table 3).
For other UA measures, such as glucose and ketones,
differences between mean values of infection category
groups were not significantly different.
Discussion
The principle finding of this study is that in adult
patients with acute GBS UTI, while mean s-QBC values
are higher than in patients with ABU, these measures
are not useful in distinguishing between these condi-
tions. These findings are noteworthy given the wide-
spread application of s-QBC values for identifying acute
UTI in patients who are culture-positive for various
organisms, including GBS. The finding that s-QBC is
not a significant prognostic indicator for acute GBS
UTI has practical implications in terms of disregarding
low s-QBC values in GBS-positive patients. Low-count
s-QBC is sometimes associated with acute infection
[14], and the data reported here suggest that interpret-
ing low-count s-QBC in GBS-positive patients as
merely transient flora, or contaminants is inappropriate.
Thus, nominal s-QBC cut-off values commonly used
such as ≥105 CFU/ml and ≥104 CFU/ml should be con-
sidered as insensitive for the diagnosis of acute GBS
UTI. The data presented here suggest that a cut-off
of ≥103 CFU/ml might be appropriate (the limit of de-
tection for most laboratories). This is consistent with re-
cent ideas highlighting the value of lower s-QBC cut-
offs in the setting of adult patients infected with other
uropathogens [30,32-34].
Semi-quantitative urinary cultures have been reported in
several studies in which over half of symptomatic patients
exhibited s-QBC values lower than the traditional cut-off of
105 CFU/ml often used for defining significant bacteruria
[35,36]. Others have reported that a ≥102 CFU/ml s-QBC
criterion may be superior to a ≥105 threshold [37,38]. In a
report by Thomsen et al. that investigated penicillin treat-
ment of patients with GBS s-QBC of any count, there was
a reduction in poor pregnancy outcomes compared to a
placebo control, also suggesting that s-QBC lower than
the traditional cut-off of 105 CFU/ml are clinically import-
ant [39]. These findings show that s-QBC values as low
as 102 CFU/ml are especially significant in pregnant
women. In the broader context, women with low-grade
bacteruria due to other uropathogens have been shown to
respond to therapy [40] supporting the notion that low-
grade s-QBC values are important for uropathogens in
general.
It is important to highlight the limitations of the current
study, and the possible implications of lowering the s-QBC
cut-off value for interpreting GBS culture-positive patients
in the diagnostic setting of UTI. Contamination of speci-
mens in the current work could not be suitably addressed
Table 3 Urinalysis data for adult patients diagnosed with acute GBS UTI or GBS ABU at University of Alabama at
Birmingham Hospital during the study period
UA for All Cases (n=245) UA for Acute UTI Cases (n=75) UA for ABU Cases (n=170) P Value
Mean s-QBC (CFU/mL) 59,792 ± 2,350 73,347 ± 3,823 53,812 ± 2,825 <0.001
Specific Gravity 1.016 ± 0.008 1.016 ± 0.008 1.005 ± 0.085 0.354
pH 6.36 ± 0.8 6.41 ± 0.1 6.33 ± 0.1 0.522
Proteinuria 0.77 ± 1.10 (118, 48.1%) 0.57 ± 0.09 (35, 46.6%) 0.86 ± 0.09 (83, 48.8%) 0.030†
Glucose 0.26 ± 0.70 (46, 19.2%) 0.21 ± 0.08 (8, 10.1%) 0.29 ± 0.05 (38, 22.4%) 0.461
Ketones 0.16 ± 0.51 (33, 13.5%) 0.13 ± 0.04 (11, 14.7%) 0.17 ± 0.04 (22, 12.9%) 0.564
Bilirubin 0.01 ± 0.11 (3, 0.01%) 0.01 ± 0.01 (1, 1.3%) 0.01 ± 0.01 (2, 1.1%) 0.918
Hematuria 0.68 ± 0.94 (119, 48.6%) 0.90 ± 0.11 (45, 60.0%) 0.59 ± 0.07 (74, 43.5%) 0.025†
Statistical Comparisons: † All Cases with UA C/W Acute GBS UTI compared to All Cases with UA C/W GBS ABU. Numbers in parentheses in columns represent the
n of subjects who exhibited a positive result for this test, followed by this number expressed as a percentage of the total n of cases in the group.
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due to the retrospective nature of the study and the unfeas-
ibility of repeat urine cultures and catheterized samples for
all patients in this setting. Overall, the number of catheter-
ized samples was low (~10%), and related to both acute
UTI and ABU patients. We defined ABU as the isolation of
urinary GBS in pure culture from a single sample, which is
an approach consistent with prior studies [14,41]. Others
have limited the definition of ABU to cases in which two-
or three-consecutive samples from an individual are
culture-positive for the same or similar organism
[32,42,43]. Our goal was to incorporate the highest number
of cases possible into our study, and its retrospective design
ruled out repeat sampling. Thus, some of the asymptomatic
women with urinary GBS in this study would represent
cases of sample contamination, especially for low count
samples, whilst others may reflect low-grade bacteruria.
Despite this limitation, data related to symptomatic patients
with low-grade s-QBC, and thus, the key finding of the
study, remain valid. Future studies of subjects with repeat
samples incorporating a higher proportion of catheterized
patients would be useful to address this.
Contamination and recovery of multiple organisms
occurs in approximately half of all urine specimens
that are positive for GBS [14], and we excluded all
such cases in the current study. In contaminated speci-
mens, other organisms may overwhelm low numbers
of GBS causing a large number of UTIs due to this or-
ganism to be missed. There were also many patients
with high GBS s-QBC but much lower numbers of
other organisms in the current study (also excluded),
which probably indicates a real infection but is dis-
counted in the diagnostic laboratory as a contaminated
specimen due to reporting. Overall, this means that
many true GBS UTI cases were probably missed in this
study (only single-organism cultures were used per case
definitions). In the broader context, such cases con-
tinue to be missed in microbiology laboratories due to
routine reporting practices in the diagnostic setting. Fi-
nally, a high prevalence of low-grade GBS bacteruria
[42] also means that revising down the s-QBC cut-off
for GBS UTI would increase the rate of false positives.
Despite these challenges, the data reported here show
that a ≥105 CFU/ml threshold is insensitive as a mar-
ker for acute GBS UTI, which provides important new
practical information for the diagnostic laboratory.
This study also suggests that age is a useful prognostic
indicator for predicting acute GBS UTI, perhaps equally
so as compared to s-QBC. Despite this, age still only
identified 3/147 acute GBS UTI patients in our patient
cohort based on a logistic regression model. The age
measure was confounded in our study because many of
the urine specimens obtained from asymptomatic
women (~25-30%) were primarily related to perinatal
screening of pregnant women. Nonetheless, patients over
the age of 40 years were shown to be at significantly
higher risk for acute GBS UTI compared to younger
patients, suggesting age may be useful as a surrogate risk
marker. This finding, against the background of high
false positive rates for acute GBS UTI, highlights the
need for careful interpretation of GBS-positive urine cul-
tures. Using age as a prognostic tool could help to iden-
tify high-risk patients and partly address the difficulties
in interpreting s-QBC values for GBS. Gender was not a
prognostic factor for discriminating infection category,
which may be more relevant to older persons and nurs-
ing home residents as discussed elsewhere [44].
GBS infection in adults is often associated with dia-
betes, which is considered a risk factor for disease due
to this organism [45]. The prevalence of ABU in diabetic
individuals is higher compared to individuals without
diabetes [46], and although diabetic patients are more
likely to have acute UTI due to any uropathogen, dia-
betes was not identified as a risk factor for GBS UTI in
a prior study [14]. This suggests that the association be-
tween diabetes and symptomatic UTI may not be as
relevant for GBS. The diabetic status of all study subjects
in the current work was not included in the medical rec-
ord review. Interestingly, however, the proportion of
individuals in the current study with ABU who exhibited
a positive test result for elevated urinary glucose was
more than double that of patients with acute GBS UTI
(22.4% vs. 10.1% respectively, a significant difference
according to Pearson Chi-Square analysis) hinting at a
possible connection. The role of diabetes in GBS UTI
and possible bias in the current dataset due to differen-
tial pregnancy rates in different patient groups will re-
quire further investigation. The association between
bacteruria and diabetes in relation to microbial sugar
metabolism also raises the possibility of growth of uro-
pathogenic organisms in urine [47]. Growth fitness in
urine has been shown for E. coli [48], but steps in the
pathogenesis of GBS UTI have only recently been
described [49-51], and a GBS isolate cultured from a pa-
tient with acute cystitis was unable to grow in urine
[51]. Proteinuria in ABU patients in this study also im-
plies that diabetes may be associated with GBS ABU.
Comparing the proteinuria and hematuria data in ABU
patients irrespective of esterase and pyuria UA findings
(possible bias per the exclusion criteria) would also be of
interest for further study.
Conclusion
This study shows that s-QBC is not useful as a prognos-
tic measure in the diagnosis of acute GBS UTI. Whilst
many laboratories continue to disregard s-QBC values
<105 CFU/ml some are now using a threshold of ≥103
CFU/ml for voided specimens containing uropathogenic
bacteria to increase the sensitivity of detection. This
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would be appropriate for GBS. This study also demon-
strates that age over 40 years is a useful surrogate mar-
ker for identifying high risk patients for acute GBS UTI.
Further investigations of ways to improve basic diagnos-
tic approaches for these important infections are now
warranted.
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